139 related articles for article (PubMed ID: 3045564)
1. Properdin, the terminal complement components, thrombospondin and the circumsporozoite protein of malaria parasites contain similar sequence motifs.
Goundis D; Reid KB
Nature; 1988 Sep; 335(6185):82-5. PubMed ID: 3045564
[TBL] [Abstract][Full Text] [Related]
2. A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite.
Robson KJ; Hall JR; Jennings MW; Harris TJ; Marsh K; Newbold CI; Tate VE; Weatherall DJ
Nature; 1988 Sep; 335(6185):79-82. PubMed ID: 3045563
[TBL] [Abstract][Full Text] [Related]
3. Characterization of mutant forms of recombinant human properdin lacking single thrombospondin type I repeats. Identification of modules important for function.
Higgins JM; Wiedemann H; Timpl R; Reid KB
J Immunol; 1995 Dec; 155(12):5777-85. PubMed ID: 7499866
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning of the cDNA coding for properdin, a positive regulator of the alternative pathway of human complement.
Nolan KF; Schwaeble W; Kaluz S; Dierich MP; Reid KB
Eur J Immunol; 1991 Mar; 21(3):771-6. PubMed ID: 2009915
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
[TBL] [Abstract][Full Text] [Related]
6. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway.
Hung SL; Peng C; Kostavasili I; Friedman HM; Lambris JD; Eisenberg RJ; Cohen GH
Virology; 1994 Sep; 203(2):299-312. PubMed ID: 8053154
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
8. The synthesis, cloning and expression of a repeating segment of the circumsporozoite surface protein of Plasmodium falciparum.
Armah GE; Nishikawa S; Kondo C; Tomita K
Nucleic Acids Symp Ser; 1988; (19):165-9. PubMed ID: 3067214
[TBL] [Abstract][Full Text] [Related]
9. Prevention of immune precipitation by purified components of the alternative pathway.
Naama JK; Holme E; Hamilton E; Whaley K
Clin Exp Immunol; 1985 Apr; 60(1):169-77. PubMed ID: 3159522
[TBL] [Abstract][Full Text] [Related]
10. Secondary structure in properdin of the complement cascade and related proteins: a study by Fourier transform infrared spectroscopy.
Perkins SJ; Nealis AS; Haris PI; Chapman D; Goundis D; Reid KB
Biochemistry; 1989 Sep; 28(18):7176-82. PubMed ID: 2819060
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
12. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
Hammer CH; Hänsch G; Gresham HD; Shin ML
J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
[TBL] [Abstract][Full Text] [Related]
13. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
[TBL] [Abstract][Full Text] [Related]
14. Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.
Beebe DP; Schreiber RD; Cooper NR
J Immunol; 1983 Mar; 130(3):1317-22. PubMed ID: 6822737
[TBL] [Abstract][Full Text] [Related]
15. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
Iwata K; Seya T; Ariga H; Nagasawa S
J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
[TBL] [Abstract][Full Text] [Related]
16. Three isoforms of complement properdin factor P in trout: cloning, expression, gene organization and constrained modeling.
Chondrou M; Papanastasiou AD; Spyroulias GA; Zarkadis IK
Dev Comp Immunol; 2008; 32(12):1454-66. PubMed ID: 18638502
[TBL] [Abstract][Full Text] [Related]
17. Neutron and X-ray scattering studies on the human complement protein properdin provide an analysis of the thrombospondin repeat.
Smith KF; Nolan KF; Reid KB; Perkins SJ
Biochemistry; 1991 Aug; 30(32):8000-8. PubMed ID: 1868073
[TBL] [Abstract][Full Text] [Related]
18. A 34-amino acid peptide of the third component of complement mediates properdin binding.
Daoudaki ME; Becherer JD; Lambris JD
J Immunol; 1988 Mar; 140(5):1577-80. PubMed ID: 3279119
[TBL] [Abstract][Full Text] [Related]
19. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
Densen P; McRill CM; Ross SC
J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
[TBL] [Abstract][Full Text] [Related]
20. PTRAMP; a conserved Plasmodium thrombospondin-related apical merozoite protein.
Thompson J; Cooke RE; Moore S; Anderson LF; Janse CJ; Waters AP
Mol Biochem Parasitol; 2004 Apr; 134(2):225-32. PubMed ID: 15003842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
